Literature DB >> 20033475

Pegylated phospholipids-based self-assembly with water-soluble drugs.

Yiguang Wang1, Ruiqi Wang, Xiaoyan Lu, Wanliang Lu, Chunling Zhang, Wei Liang.   

Abstract

PURPOSE: To investigate the self-assembly of polyethylene glycol (PEG)-phosphatidylethanolamine (PE) conjugate with water-soluble drugs (doxorubicin hydrochloride, vinorelbine tartrate and vincristine sulfate) and give insight into the mechanism of formation and mode of interaction of the drug with PEG-PE as well as the general principles of self-assembly using pegylated lipid micelles.
METHODS: One-step self-assembly method to prepare drug-loaded micelles was developed. The micelles were characterized by dynamic light scattering, transmission electron microscopy, encapsulation efficiency, and release study. NMR was used to study molecular assembly of PEG-PE with doxorubicin.
RESULTS: Doxorubicin hydrochloride and vinorelbine tartrate were entrapped into micelles with high efficiency of >99.0% at molar ratios of 1:1 and 2:1 of PEG-PE to drugs, respectively. Drug loading did not measurably perturb either the geometry or the size. It was found that electrostatic interaction and hydrophobic forces are responsible for the intercalation of drugs into PEG-PE micelles. NMR data revealed that the anthracycline ring of doxorubicin was inserted between PE phospholipids, and its amino sugar located in the outer shell of micelle between PEG chains.
CONCLUSION: Based on our results, the structure and self-assembly mechanism of water-soluble drugs encapsulated in PEG-PE micelles were proposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033475     DOI: 10.1007/s11095-009-0029-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  1H NMR quantification of poly(ethylene glycol)-phosphatidylethanolamine in phospholipid mixtures.

Authors:  E A Vernooij; C A Gentry; J N Herron; D J Crommelin; J J Kettenes-van den Bosch
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

Review 2.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

3.  Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

Authors:  Keun Seok Lee; Hyun Cheol Chung; Seock Ah Im; Yeon Hee Park; Chul Soo Kim; Sung-Bae Kim; Sun Young Rha; Min Young Lee; Jungsil Ro
Journal:  Breast Cancer Res Treat       Date:  2007-05-03       Impact factor: 4.872

4.  Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma.

Authors:  Jun-ichiro Kuroda; Jun-ichi Kuratsu; Masahiro Yasunaga; Yoshikatsu Koga; Yohei Saito; Yasuhiro Matsumura
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

5.  Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles.

Authors:  Ronak Vakil; Glen S Kwon
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

Review 6.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.

Authors:  Anatoly N Lukyanov; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2004-05-07       Impact factor: 15.470

7.  PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effect.

Authors:  Tiziana Musacchio; Valentino Laquintana; Andrea Latrofa; Giuseppe Trapani; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

Review 8.  Poly (amino acid) micelle nanocarriers in preclinical and clinical studies.

Authors:  Yasuhiro Matsumura
Journal:  Adv Drug Deliv Rev       Date:  2008-02-09       Impact factor: 15.470

9.  Roles of nonpolar and polar intermolecular interactions in the improvement of the drug loading capacity of PEO-b-PCL with increasing PCL content for two hydrophobic Cucurbitacin drugs.

Authors:  Sarthak K Patel; Afsaneh Lavasanifar; Phillip Choi
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988

Review 10.  Polymeric micelles for delivery of poorly water-soluble compounds.

Authors:  Glen S Kwon
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2003       Impact factor: 4.889

View more
  18 in total

1.  An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance.

Authors:  Jianqin Lu; Wenchen Zhao; Hao Liu; Rebecca Marquez; Yixian Huang; Yifei Zhang; Jiang Li; Wen Xie; Raman Venkataramanan; Liang Xu; Song Li
Journal:  J Control Release       Date:  2014-10-24       Impact factor: 9.776

2.  Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.

Authors:  Xiuli Wei; Yiguang Wang; Wenfeng Zeng; Feng Huang; Lei Qin; Chunling Zhang; Wei Liang
Journal:  Pharm Res       Date:  2012-03-17       Impact factor: 4.200

3.  Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.

Authors:  Patty Wong; Lin Li; Junie Chea; Melissa K Delgado; Erasmus Poku; Barbara Szpikowska; Nicole Bowles; Megan Minnix; David Colcher; Jeffrey Y C Wong; John E Shively; Paul J Yazaki
Journal:  Cancer Biother Radiopharm       Date:  2017-09       Impact factor: 3.099

4.  Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer.

Authors:  Zhuoran Gong; Min Chen; Qiushi Ren; Xiuli Yue; Zhifei Dai
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

5.  Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment.

Authors:  Christopher A Quinto; Priya Mohindra; Sheng Tong; Gang Bao
Journal:  Nanoscale       Date:  2015-07-08       Impact factor: 7.790

6.  Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.

Authors:  Shallu Kutlehria; Gautam Behl; Ketan Patel; Ravi Doddapaneni; Imran Vhora; Nusrat Chowdhury; Arvind Bagde; Mandip Singh
Journal:  AAPS PharmSciTech       Date:  2017-10-10       Impact factor: 3.246

7.  Surface analysis of PEGylated nano-shields on nanoparticles installed by hydrophobic anchors.

Authors:  M F Ebbesen; B Whitehead; B Ballarin-Gonzalez; P Kingshott; K A Howard
Journal:  Pharm Res       Date:  2013-04-12       Impact factor: 4.200

8.  Characterization of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[Methoxy(polyethylene glycerol)-2000] and Its Complex with Doxorubicin Using Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics.

Authors:  Weidong Hu; Allen Mao; Patty Wong; Adrien Larsen; Paul J Yazaki; Jeffrey Y C Wong; John E Shively
Journal:  Bioconjug Chem       Date:  2017-06-09       Impact factor: 4.774

9.  Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.

Authors:  Shuhang Wang; Jingxin Gou; Yue Wang; Xinyi Tan; Linxuan Zhao; Xiangqun Jin; Xing Tang
Journal:  Int J Nanomedicine       Date:  2021-03-22

10.  Antibody Targeted PET Imaging of 64Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors.

Authors:  Patty Wong; Lin Li; Junie Chea; Weidong Hu; Erasmus Poku; Todd Ebner; Nicole Bowles; Jeffrey Y C Wong; Paul J Yazaki; Stephen Sligar; John E Shively
Journal:  Bioconjug Chem       Date:  2020-01-30       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.